BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32586317)

  • 1. The association between cystatin C and COPD: a meta-analysis and systematic review.
    Chai L; Feng W; Zhai C; Shi W; Wang J; Yan X; Wang Q; Zhang Q; Li M
    BMC Pulm Med; 2020 Jun; 20(1):182. PubMed ID: 32586317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Cystatin C as an Inflammatory Marker in Exacerbated and Convalescent COPD Patients.
    Zhang M; Li Y; Yang X; Shan H; Zhang Q; Ming Z; Xie Y; Chen H; Liu Y; Zhang J
    Inflammation; 2016 Apr; 39(2):625-31. PubMed ID: 26613760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Surfactant Protein D is a Potential Biomarker for Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis.
    Wang H; Li F; Huang H; Wu F; Chen L; Zhang D; Zhang T; Wan Y
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis.
    Zhu M; Wang T; Wang C; Ji Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2597-2607. PubMed ID: 27799758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Vitamin D on Respiratory Function and Immune Status for Patients with Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis.
    Yang H; Sun D; Wu F; Xu X; Liu X; Wang Z; Zhou L
    Comput Math Methods Med; 2022; 2022():2910782. PubMed ID: 35313462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review.
    Tong X; Wang D; Liu S; Ma Y; Li Z; Tian P; Fan H
    Int J Chron Obstruct Pulmon Dis; 2018; 13():409-418. PubMed ID: 29430175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum adiponectin concentrations and chronic obstructive pulmonary disease: a meta-analysis.
    Lin YH; Jiang TX; Hu SX; Shi YH
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32129463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of vitamin D therapy for patients with COPD: a meta-analysis of randomized controlled trials.
    Li X; He J; Yu M; Sun J
    Ann Palliat Med; 2020 Mar; 9(2):286-297. PubMed ID: 32156131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis.
    Su X; Lei T; Yu H; Zhang L; Feng Z; Shuai T; Guo H; Liu J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():811-825. PubMed ID: 37197601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Vitamin C Supplementation on Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis.
    Lei T; Lu T; Yu H; Su X; Zhang C; Zhu L; Yang K; Liu J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2201-2216. PubMed ID: 36118282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese Medical Injections for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Network Meta-analysis.
    Hu H; Ji Z; Qiang X; Liu S; Sheng X; Chen Z; Liu F; Wang H; Zhang J
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3363-3386. PubMed ID: 34949918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Huang Q; Xiong H; Shuai T; Wang Y; Zhang C; Zhang M; Zhu L; Lu J; Liu J
    Ther Adv Respir Dis; 2020; 14():1753466620938546. PubMed ID: 32643535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C and Risk of Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
    Nair P; Misra S; Nath M; Vibha D; Srivastava AK; Prasad K; Kumar P
    Dement Geriatr Cogn Disord; 2020; 49(5):471-482. PubMed ID: 33075778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ratio Serum Creatinine/Serum Cystatin C (a Surrogate Marker of Muscle Mass) as a Predictor of Hospitalization in Chronic Obstructive Pulmonary Disease Outpatients.
    Amado CA; García-Unzueta MT; Lavin BA; Guerra AR; Agüero J; Ramos L; Muñoz P
    Respiration; 2019; 97(4):302-309. PubMed ID: 30481791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cystatin C as a potential biomarker for the evaluation COPD.
    Zhang Y; Zhu Y; Wu Y; Wang G; Xie X; Ke R; Li S; Liu L; Fen W; Li F; Li F; Li M
    Int J Clin Exp Med; 2014; 7(12):5484-90. PubMed ID: 25664059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating JNK pathway-associated phosphatase: A novel biomarker correlates with Th17 cells, acute exacerbation risk, and severity in chronic obstructive pulmonary disease patients.
    Gao W; Gao L; Yang F; Li Z
    J Clin Lab Anal; 2022 Jan; 36(1):e24153. PubMed ID: 34918391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between tumor necrosis factor-α and chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Yao Y; Zhou J; Diao X; Wang S
    Ther Adv Respir Dis; 2019; 13():1753466619866096. PubMed ID: 31390957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between serum galectin-3 and chronic obstructive pulmonary disease: A meta-analysis.
    Zhao X; Han B; Tang W; Ji S; Wang L; Huang J; Hu Y; Li J
    Biomol Biomed; 2024 May; ():. PubMed ID: 38801251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between IL-17 and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
    Ma R; Su H; Jiao K; Liu J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1681-1690. PubMed ID: 37551391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Markers and the Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
    Su B; Liu T; Fan H; Chen F; Ding H; Wu Z; Wang H; Hou S
    PLoS One; 2016; 11(4):e0150586. PubMed ID: 27104349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.